Advanced Medical Solutions Group (LON:AMS) Share Price Passes Above Two Hundred Day Moving Average - Should You Sell?

Key Points

• Advanced Medical Solutions Group's share price passed above its 200-day moving average, trading as high as GBX 252 and last at GBX 249.93 on volume of about 2.07 million shares versus a 200‑day MA of GBX 214.53.
• Analyst sentiment is broadly positive with a consensus "Moderate Buy" (three Buys, one Hold) and a consensus target of GBX 270.25; Berenberg and RBC have targets of GBX 300 and GBX 260 respectively.
• Financials show a market cap of £540.9m and a high valuation (P/E 55.3) paired with modest profitability (net margin 4.35%, ROE 3.87%) and moderate leverage (debt/equity 31.5), implying growth expectations despite thin margins.

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 214.53 and traded as high as GBX 252. Advanced Medical Solutions Group shares last traded at GBX 249.93, with a volume of 2,072,851 shares trading hands.

Analyst Ratings Changes

AMS has been the topic of a number of research reports. Berenberg Bank reissued a "buy" rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a report on Wednesday, March 18th. Royal Bank Of Canada reiterated a "sector perform" rating and issued a GBX 260 price target on shares of Advanced Medical Solutions Group in a research report on Thursday, April 9th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat, Advanced Medical Solutions Group currently has a consensus rating of "Moderate Buy" and a consensus target price of GBX 270.25.

Advanced Medical Solutions Group Price Performance

The firm has a market cap of £540.87 million, a P/E ratio of 55.30, a P/E/G ratio of 5.00 and a beta of 0.63. The company has a fifty day moving average of GBX 210.29 and a 200-day moving average of GBX 214.53. The company has a debt-to-equity ratio of 31.50, a current ratio of 2.79 and a quick ratio of 4.58.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last announced its earnings results on Wednesday, March 18th. The company reported GBX 11.98 EPS for the quarter. Advanced Medical Solutions Group had a net margin of 4.35% and a return on equity of 3.87%. On average, sell-side analysts anticipate that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.